Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality. Now, to cover its bo...

Novartis and Incyte have already pitted their blockbuster JAK inhibitor Jakafi against COVID-19 as a possible treatment for a severe respiratory immune reaction. Now...

Turkish Cargo, the fastest growing air cargo brand in the world, achieved the highest growth rate among the best 25 air cargo carriers with 16.6 percent growth rate,...

One-year data from the FIREFISH Part 2 study, a global study evaluating Roche's risdiplam in infants aged one - seven months old with symptomatic Type 1 spinal muscu...

Shares in Blueprint Medicines took a significant hit after it emerged that its Ayvakit (avapritinib) failed to best Bayer's Stivarga (regorafenib) in patients with g...

The government is introducing a new system for reporting data on COVID-19 deaths in order to capture a more accurate picture of the virus' toll. To date, only data...

As of this morning – Wednesday April 29 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 161,145 with 21,678 deaths. England’s nation...

Despite widespread disruption, ACG is continuing production in its factories across the world, and helping to keep supply chains running smoothly to meet mission-cri...

Bristol Myers Squibb and Exelixis have announced that a late-stage study testing a combination of Opdivo (nivolumab) and Cabometyx (cabozantinib) has hit its primary...

Novartis has reached an agreement with US regulators to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalised patients with COVID-19 disease....